The new PsA filing is based on the results of two phase 3 trials of Tremfya – DISCOVER-1 and DISCOVER-2 – that met the primary endpoint of a 20% improvement in PsA symptoms (ACR 20 response ...

AbbVie’s immunology blockbusters Rinvoq and Skyrizi took the first and second ... thanks to just under $20 million spent on a trio of ads for the drug’s uses in treating depression and ...

Skyrizi (risankizumab-rzaa) is prescribed for Crohn’s disease and certain other inflammatory conditions. As with other drugs, Skyrizi can cause side effects, such as headache and injection site ...

Skyrizi is a key part of AbbVie's strategy to negotiate the $20 billion patent cliff from Humira, which has already seen sales decline outside of the US where it has already lost protection from ...

— Recommendations are independently chosen by our editors. Purchases you make through our links may earn us and our publishing partners a commission. Oh, to count the ways we love Brooklinen ...

March 7 (UPI) --A group of 20 attorneys general filed suit against the Trump administration over its firing of federal workers. Attorneys general from 19 states and Washington sought a court order ...

In a 149-141 overtime win over the Phoenix Suns, the Denver Nuggets superstar posted a 30-20-20 game, an unprecedented stat line perfectly in line with his all-time great passing ability as a big man.

The three-time NBA MVP had the league’s first 30-20-20 triple-double in the Denver Nuggets’ 149-141 overtime victory over the Phoenix Suns on Friday night. Jokic had 31 points, 21 rebounds and ...

Mind you, it's not your run-off-the-mill Viper either, but the ACR, as highlighted by the sporty aero, including that massive wing that decorates the trunk lid. The car has an extremely aggressive ...

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...

Spain 20 Year Government Bond-0.0040 3.9467% ...

The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. Estimates data is a third party aggregated data provided by S&P Global Market Intelligence LLC ...